November 19, 2021 — Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
November 19, 2021
November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating ...
November 18, 2021
November 18, 2021 — Adults undergoing mitral valve surgery who have less than severe leakage of the tricuspid valve may ...
November 18, 2021
November 18, 2021 — Village doctors who were community health workers in rural China were trained and successfully ...
November 18, 2021
November 17, 2021 — Canagliflozin, a medication used to treat type 2 diabetes, was found to greatly improve symptoms and ...
November 17, 2021
November 17, 2021 — For people experiencing severe aortic stenosis who do not have symptoms or need symptom relief ...
November 17, 2021
Srihari Naidu, M.D., FACC, FAHA, FSCAI, is the director of both the cardiac cath labs and Hypertrophic Cardiomyopathy ...
November 16, 2021
November 12, 2021 — Orchestra BioMed Inc. announced multiple presentations of long-term clinical results and ISH ...
November 12, 2021
Feature | Cardiovascular Business | By Dave Fornell, DAIC Editor
November 12, 2021 — President Joe Biden today announced his intention to nominate cardiologist Robert Califf, M.D., MACC ...
November 12, 2021
November 10, 2021 — Medtronic presented early data for its self-expanding Intrepid transcatheter mitral valve ...
November 10, 2021
November 10, 2021 — Shockwave Medical, a developer of Intravascular Lithotripsy (IVL) to treat complex calcified ...
November 10, 2021
November 10, 2021 — Ancora Heart Inc., a company developing a novel therapy to address heart failure, announced results ...
November 10, 2021
November 10, 2021 — There were nine late-breaking trials and 13 late-breaking science presentations at the 2021 Transcat ...
November 10, 2021
November 9, 2021 — Results from the largest randomized trial available comparing different closure device strategies ...
November 09, 2021
November 9, 2021 — Six-month outcomes from the randomized RADIANCE-HTN TRIO Trial comparing endovascular ultrasound ...
November 09, 2021